Skip to content

Psilocybin: all studies

Page 387 of 440: studies 3,861 to 3,870 of 4,392, newest first. Back to the psilocybin overview

Research

Ketamine Pharmacodynamics Entangled: Comment.

Anesthesiology December 1, 2022 T. Andrew Bowdle, Nathan Sackett, Rick J. Strassman et al. 5 citations

We read with interest the study of ketamine psychedelic and analgesic effects by Olofsen et al.1 and the accompanying editorial by Mashour.2 In both articles, the authors refer to the “dissociative” effects of ketamine. Corssen and Domino3 originally used the term “dissociative” in 1966 to describe “patients and subjects who, during recovery from CI-581 [ketamine], felt as though they were in...

DOI: 10.1097/aln.0000000000004349 (opens in new tab) Ketamine Mechanism of action Therapeutic effects Neuroscience research

The Cultural Use of Mushrooms

Royal Society of Chemistry eBooks November 23, 2022 Jovana Vunduk, Alona Yu. Biketova 4 citations

Far from being among the hottest scientific topics and a cultural hype, mushrooms have a long history of cultural uses. Food and medicinal uses are the best known and most recorded ones. Who feasted on mushroom-loaded extravagant banquets? Which species are considered among the tastiest? Which ancient texts spoke about mushroom medicine? What is the future of medicinal mushroom use, and how has...

Psychedelic compounds directly excite 5-HT 2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT 2A Gq -mediated activation mechanism

bioRxiv (Cold Spring Harbor Laboratory) November 15, 2022 Gavin P. Schmitz, Yi-Ting Chiu, Gabriele M. König et al. 15 citations preprint

Summary Psilocin, the active compound in Psilocybe sp . mushrooms, is a serotonergic psychedelic that has recently gained renewed interest due to its potential as a therapeutic tool. Despite promising clinical findings, the underlying signaling mechanisms and brain region-specific effects of psilocin and other psychedelic drugs remain unclear. Psilocin, like other psychedelic compounds, is an...

Rapid-Response Treatments for Depression and Requests for Physician-Assisted Death: An Ethical Analysis.

American Journal of Geriatric Psychiatry November 1, 2022 Noah Berens, Scott Yh Kim 12 citations

Depression is common at the end of life, and there is longstanding concern that it may affect terminally ill patients' decisions to request physician-assisted death (PAD). However, it is difficult for clinicians to determine the role of depression in a patient's PAD request. A recent case series described rapid responses to intranasal ketamine in three patients with terminal illness and...

DOI: 10.1016/j.jagp.2022.07.003 (opens in new tab) Full text (opens in new tab) Depression Physician-assisted death Decision-making capacity Ethics

Psychedelics for Use and Wellbeing Cultural Context and Recent Developments: A Jamaican Perspective

Online Journal of Complementary & Alternative Medicine October 28, 2022 Winston de la Haye 2 citations

Proclaimed as the "new frontier" in psychiatry, the use of Psychedelics, including Psilocybin as a treatment for mental health and wellbeing has gained momentum over the last few years [1,2].The scientific progress and clinical promise of this movement owes much of its success to the history of indigenous healing practices.Though "discovered" in 1956 by Roger Heim [3], the history of Psilocybin...

DOI: 10.33552/ojcam.2022.08.000676 (opens in new tab) Full text (opens in new tab) Perspective graphical Context archaeology Visual arts

Trip Reports

Lund University Publications (Lund University) October 27, 2022 Jonas Bååth, Johan Nordgren 1 citation

Background: Experiences of intoxication elude scientific research because of their immediate and 'inner' nature for the intoxicated individual. In this chapter, we show how 'trip reports' – reports of psychedelic intoxication – from online drug information forums and libraries allow for further understanding the experience of psychedelic intoxication from LSD, DMT and psilocybin by examining...

Complexities of psychedelics for therapeutic use in obesity and eating disorders

Journal of Psychiatry and Neuroscience October 25, 2022 A. Reichelt

In an interesting and timely editorial, Borgland and Neyens provide a snap­ shot of preclinical research that could support the development of psyche­ delic drugs as part of a therapeutic regimen in individuals with obesity or eating disorders (EDs), including an­ orexia nervosa (AN) and binge eating disorder (BED).1 The role of the sero­ tonergic system in appetite was key in the development...

Preparing for psychedelic therapies in Australia

October 18, 2022 Paul Liknaitzky

Psychedelic therapies have the potential to treat mental illness but there’s still a long way to go. After decades in the wilderness, psychedelic therapies are making a comeback into clinical research and are poised to re-enter medical care. When used alongside psychotherapy, drugs like psilocybin (found in ‘magic mushrooms’) and MDMA (found in ‘ecstasy’) have […]

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy

Frontiers in Psychiatry October 12, 2022 Robert J Sottile, Thomas Vida 30 citations

Post-traumatic stress disorder (PTSD) is a devastating psychiatric disorder afflicting millions of people around the world. Characterized by severe anxiety, intrusive thoughts, pervasive nightmares, an assortment of somatic symptoms, associations with severe long-term health problems, and an elevated risk of suicide, as much as 40–70% of patients suffer from refractory disease....

O Renascimento da Medicina Psicodélica

E-Acadêmica October 10, 2022 Roberto Carlos Moreira Kuligowski, Eduarda Maria Schroeder, João Vitor Pelizzari et al.

Introduction: Studies about alternative medicine have multiplied in several countries such as the United States, Norway and England in recent years. Among them, I highlight psychedelic medicine that through randomized clinical trials, has already shown that psilocybin - substance present in the Psilocybe cubensis mushroom, popularly known as "magic mushrooms" - was able to induce remission of...